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ABSTRACT 
A novel series of isoindolinotriazole derivatives with different substituents in the triazole moiety were synthesized 
via copper-catalyzed cycloaddition (CuAAC) click chemistry between 2-(meta- or para-ethynylphenyl)-4,6-
dimethoxyisoindolin-1-ones and several azides. The synthesized triazoles were characterized by IR, 
1
H NMR, 
13
C NMR 
and mass spectral techniques. 
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INTRODUCTION  
Isoindolinones are interesting heterocyclic compounds due to their presence in many naturally occurring 
substances [1,2] and because of their extensive biological properties such as antihypertensive [3], antipsychotic [4] 
anxiolytic [5] and antiviral [6]. 
In medicinal chemistry, the triazoles are known to possess a number of desirable features including sufficient stability to 
acidic/basic hydrolysis and reductive/oxidative conditions, indicative of a high aromatic stabilization [7]. This moiety is 
relatively resistant to metabolic degradation. Tazobactam, a b-lactamase inhibitor is among the best-known examples of 
triazole containing structures with the broad-spectrum antibiotic piperacillin [8]. Also several members of the 1,2,3-triazole 
family have indeed shown interesting biological properties, such as anti-allergic, anti-bacterial and anti-HIV activity [9,10]. 
The coupling of two or more molecular entities with distinct properties to form novel conjugates with combined 
properties of parent components, has emerged as a fast growing technology in recent years [11,12]. Several new 
conjugates arising via such bioconjugation have been found to exhibit unusual biological properties and activities as the 
different molecular segments act cooperatively [13]. In this prospective, the ‘Click’-chemistry [14] is a newer approach for 
the synthesis of drug-like molecules that can accelerate the drug discovery process by utilizing a few practical and reliable 
reactions [15]. Among the reactions comprising the click universe, the perfect example is the Huisgen 1,3-dipolar 
cycloaddition of terminal alkynes and organic azides to form 1,4-disubstituted-1,2,3-triazoles [16,17]. 
In this study, we report the high-yielding synthesis of novel isoindolinotriazoles 3a-h using 1,3-dipolar 
cycloaddition reaction of ethynylisoindolinones 2a-b with several azides in the presence of Cu(I) catalyst at room 
temperature. All the synthesized isoindolinones and 1,4-disubstituted-1H-1,2,3-triazoles were characterized by IR, 
1
H 
NMR, 
13
C NMR spectroscopy and mass spectrometry. 
RESULTS AND DISCUSSION 
Isoindolinone derivatives were obtained using methods developed by Yoo et al. [18] (Scheme 1). The reaction 
between methyl 2-formyl-3,5-dimethoxybenzoate 1 with the appropriate amines in methanol was carried at room 
temperature over 1 h. The resulting solution was mixed with sodium borohydride at 0 °C and reacted overnight at room 
temperature to produce isoindolinone compounds 2a-d (Table 1). 
 
CHO
CO2Me
OMe
MeO
OMe
MeO
N
O
R1
OMe
MeO
N
O
OMe
MeO
N
O
N
N
N
R2
H2N R
1
N3 R
2
N O
F
N
+
+
1 2a-d
2a-b 3a-h
R1:
F Cl
SR
2:
;
; ;
;
;
;
i
ii
 
 
Scheme 1. Synthesis of isoindolinones 2a-d and 1H-1,2,3-triazoles 3a-h. Reagents and conditions: (i) NaBH4, MeOH, 0 
°C-r.t., 20 h. (ii) Na-ascorbate (0.45 equiv), CuSO4.5H2O (0.1 equiv), THF/t-BuOH/H2O (3 :1 :1, v/v/v), r.t., 2 d. 
 
The (3 + 2) cycloaddition of 2-(meta- or para-ethynylphenyl)-4,6-dimethoxyisoindolin-1-ones with different azides (Scheme 
1) in the presence of Na-ascorbate, THF/t-BuOH/H2O and CuSO4.5H2O, at room temperature resulted in the 
corresponding 1,4-disubstituted-1,2,3-triazole compounds 3a-h in good yields (Table 1). 
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Table 1: Synthesis of isoindolinones 2a-d and 1,4-disubstituted-1,2,3-triazoles 3a-h. 
Entry Compounds Structure Yields
a 
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a 
isolated yield 
The structures of the isoindolinones were determined primarily from spectroscopic data. The IR spectra showed 
bands in the range of 1700-1680 cm
-1
 which confirmed the presence of a C=O function. The 
13
C-NMR spectra confirmed 
the formation of the isoindolinone ring with signals of the C=O function at δ = 166-168 ppm and CH2 at the δ = 47.80 – 
48.26 ppm. The mass spectra showed the respective [M + H]
+
 peaks.  
The formation of triazole was confirmed by the presence of absorption band in the region 3188-3105 cm
-1
 in IR 
spectra due to =C-H stretching of triazole ring. The presence of characteristic singlet in 
1
H NMR due to triazolyl protons in 
the region of δ 7.64-8.71 and δ 119.1-121.3 in 
13
C NMR due to C-5 of the triazole ring confirmed the formation of triazole 
ring. The results obtained from mass spectral analysis were found in accordance to their molecular weights. 
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CONCLUSION 
In summary, various isoindolinones were synthesized and utilized as starting materials in the ‘click’ reaction to 
attach azido residues. Consequently, we have employed these, in house synthesized precursors, to prepare a new class 
of hybrid molecules 1,4-disubstituted-1H-1,2,3-triazoles employing already known chemistry of (3 + 2) cycloaddition of 
azides and alkynes in good to very good yields. All products that we have obtained were hitherto unknown. A number of 
them are presently under pharmacological screening. 
EXPERIMENTAL 
General 
Melting points were determined with an Electrothermal 9300 capillary melting point apparatus and are 
uncorrected. IR spectra were recorded on a Perkin-Elmer PARAGON 1000 FT-IR spectrometer. 
1
H and 
13
C NMR spectra 
were recorded on an AC Bruker spectrometer at 300 MHz (
1
H) and 75 MHz (
13
C) using (CD3)2SO or CDCl3 as solvents. 
High resolution mass spectra (HRMS) were recorded on a Bruker Maxis spectrometer (Service Commun Toulouse, 
France). Silica Gel 60 (Merck 70–230) was used for column chromatography. The progress of the reactions was 
monitored by thin layer chromatography (TLC) on Kieselgel 60 F254 (Merck) plates. Compound purity was determined by 
an LC-PDA-MS method and was found to be in the range 96-99%. 
General experimental procedure for preparation of 2-substitued-4,6-
dimethoxyisoindolin-1-ones 
To a solution of methyl 2-formyl-3,5-dimethoxybenzoate 1 (2.5 mmol) in methanol (20 mL) was added the 
appropriate amine (2.5 mmol). The mixture was stirred at room temperature until the appearance of a suspension. NaBH4 
(5 mmol) was then added at 0 °C and the mixture allowed to react at room temperature for 20 h with stirring. The 
precipitate thus formed was filtered through a glass filter to give a solid compound. 
2-(4-ethynylphenyl)-4,6-dimethoxyisoindolin-1-one (2a) 
White solid, yield (51%), mp 186-188 °C. IR (KBr) cm-1: 3271 (C≡H), 2915, 2834, 1697 (C=O), 1627, 1607, 1504, 1448, 1384, 1362, 
1320, 1294, 1201, 1141, 1118, 1048, 934, 830, 762, 635, 518. 1H NMR (300 MHz, DMSO-d6) δ: 3.85 (s, 3H, CH3), 3,89 (s, 3H, CH3), 
4.15 (s, 1H, CH), 4.84 (s, 2H, CH2), 6.82-6.83 (d, J= 3 Hz, 1H), 6.86-6.87 (d, J= 3 Hz, 1H), 7.51-7.54 (m, 2H), 7.93-7.96 (m, 2H). 
13C 
NMR (75 MHz, DMSO-d6) δ: 48.3 (CH2), 56.2 (CH3), 56.2 (CH3), 80.8 (CH), 83.8 (C), 98.4 (CH), 103.7 (CH), 117.3 (C), 119.3 (2 
CH), 121.88 (C), 132.9 (2 CH), 134.7 (C), 140.4 (C), 155.4 (C), 162.0 (C); 167.2 (C). MS-(+)ESI: m/z (%): 294 ([M+H]+, 100). HR-
MS (ESI) m/z calcd for C18H16NO3 [M+H]
+ 294.1130. Found 294.1137. 
2-(3-ethynylphenyl)-4,6-dimethoxyisoindolin-1-one (2b) 
White solid, yield (59%), mp 191-193 °C. IR (KBr) cm
-1
: 3240 (C≡H), 2960, 2833, 1686 (C=O), 1615, 1577, 1504, 1429, 
1384, 1329, 1239, 1208, 1140, 1120, 1061, 945, 815, 788, 682. 
1
H NMR (300 MHz, DMSO-d6) δ: 3.85 (s, 3H, CH3), 3,90 
(s, 3H, CH3), 4.24 (s, 1H, CH), 4.87 (s, 2H, CH2), 6.83-6.84 (d, J= 3 Hz, 1H), 6.87-6.88 (d, J= 3 Hz, 1H), 7.26-7.29 (m, 1H), 
7.41-7.47 (t, J= 9 Hz, 1H), 7.90-7.94 (m, 1H), 8.08-8.09 (t, J= 3 Hz, 1H). 
13
C NMR (75 MHz, DMSO-d6) δ: 48.3 (CH2), 56.2 
(CH3), 56.2 (CH3), 81.4 (CH), 83.8 (C), 98.4 (CH), 103.7 (CH), 120.2 (CH), 121.9 (C), 122.5 (CH), 122.7 (C), 127.6 (CH), 
129.8 (CH), 134.7 (C), 140.2 (C), 155.5 (C), 162.0 (C); 167.2 (C); MS-(+)ESI m/z: 294 ([M+H]
+
, 100%). HRMS-ESI (m/z): 
calcd for C18H16NO3 [M+H]
+ 
294.1130 found: 294.1139. 
2-(4-(dimethylamino)phenyl)-4,6-dimethoxyisoindolin-1-one (2c) 
White solid, yield 64%, mp: 152-153 °C. IR (KBr) cm
-1
: 1692, 1683 (C=O), 1614, 1522, 1326, 1270, 1207, 1146, 1110, 
1050, 944, 808. 
1
H NMR (300 MHz, DMSO-d6) δ: 2.89 (s, 6H, CH3), 3.84 (s, 3H, CH3), 3.88 (s, 3H, CH3), 4.74 (s, 2H, 
CH2), 6.76-6.79 (m, 3H), 6.83 (d, J = 3 Hz, 1H), 7.64-7.67 (m, 2H). 
13
C NMR (75 MHz, DMSO-d6) δ: 40.8 (2 CH3), 48.8 
(CH2), 56.1 (CH3), 56.2 (CH3), 98.3 (CH), 102.9 (CH), 113.1 (2 CH), 121.5 (C), 121.6 (2 CH), 129.6 (C), 135.4 (C), 148.1 
(C), 155.4 (C), 161.9 (C), 166.3 (C). MS-(+)ESI m/z: 313 ([M+H]
+
, 100%). HRMS-ESI (m/z): calcd for C18H21N2O3 [M+H]
+
 
313.1552 found: 313.1551. 
2-(3-fluoro-4-morpholinophenyl)-4,6-dimethoxyisoindolin-1-one (2d) 
White solid, yield 79%, mp: 204-205 °C. IR (KBr) cm
-1
: 2949, 2840, 1688 (C=O), 1627, 1512, 1363, 1328, 1270, 1204, 
1146, 1129, 1118, 1054, 1042, 935, 824. 
1
H NMR (300 MHz, CDCl3) δ: 3.10 (t, J = 3 Hz, 4H, CH2), 3.88 (t, J = 3 Hz, 4H, 
CH2), 3.89 (s, 3H, CH3), 3.90 (s, 3H, CH3), 4.67 (s, 2H, CH2), 6.64 (d, J = 3 Hz, 1H), 6.95-7.01 (m, 2H), 7.48 (dd, J = 3, 9 
Hz,1H), 7.79 (dd, J = 3, 9 Hz, 1H). 
13
C NMR (75 MHz, CDCl3) δ: 48.4 (CH2), 51.0 ( CH2), 51.1 ( CH2), 55.6 (CH3), 55.9 
(CH3), 67.0 (2 CH2), 97.9 (CH), 103.0 (CH), 108.4 (CH), 114.7 (CH), 118.8 (CH), 121.1 (C), 135.1 (C), 136.4 (C), 153.9 
(C), 155.1 (C), 157.1 (C), 162.0 (C), 167.3 (C); MS-(+)ESI m/z: 373 ([M+H]
+
, 100%). HRMS-ESI m/z: calcd for 
C20H22FN2O4 [M+H]
+
 373.1564 found: 373.1555. 
General experimental procedure for preparation of 1,4-disubstituted-1,2,3-triazoles 
The mixture of alkyne 2a or 2b (1 mmol) and azides (1 mmol) was suspended in a mixture of THF/t-BuOH/H2O 
(3:1:1, v/v/v, 6/2/2 mL). Sodium ascorbate (89 mg, 0.45 equiv) was added followed by addition of CuSO4.5H2O (16 mg, 
0.1 equiv.). The heterogeneous mixture was stirred vigorously for 2 days, at which time TLC showed complete conversion. 
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The reaction mixture was concentrated under vacuum and the residue was treated with H2O (50 mL) and extracted with 
dichloromethane (3 × 15 mL). The combined organic extracts were dried over anhydrous Na2SO4, filtered and evaporated 
under reduced pressure to give a crude mass. Column chromatography purification using ethyl acetate/dichloromethane 
as eluent gave the clicked product [16,17]. 
4,6-dimethoxy-2-(4-(1-(phenylthiomethyl)-1H-1,2,3-triazol-4-yl)phenyl)isoindolin-1-one (3a) 
White solid, yield (70%), mp: 194-196 °C. IR (KBr) cm
-1
: 3140, 3055, 2942, 2841, 1688 (C=O), 1629, 1612, 1502, 1453, 
1384, 1361, 1322, 1267, 1202, 1145, 1120, 1074, 1041, 972, 929, 832, 802, 764, 738, 689, 515, 472. 
1
H NMR (300 MHz, 
DMSO-d6) δ: 3.86 (s, 3H, CH3), 3,90 (s, 3H, CH3), 4.87 (s, 2H, CH2), 6.00 (s, 2H, CH2), 6.82-6.83 (d, J= 3 Hz, 1H), 6.87-
6.88 (d, J= 3 Hz, 1H), 7.30-7.39 (m, 2H), 7.44-7.47 (m, 3H), 7.86-7.89 (m, 2H) 7.98-8.01 (m, 2H), 8.55 (s, 1H, CHtriazole). 
13
C NMR (75 MHz, DMSO-d6) δ: 48.4 (CH2), 52.41 (CH2), 56.2 (CH3), 56.2 (CH3), 98.4 (CH), 103.6 (CH), 119.8 (2 CH), 
121.1 (CHtriazole), 121.8 (C), 126.2 (2 CH), 126.5 (C), 128.2 (CH), 129.8 (2 CH), 131.1 (2 CH), 132.9 (C), 134.9 (C), 139.7 
(C), 146.8 (Cq triazole), 155.5 (C), 162.0 (C); 167.0 (C). MS-(+)ESI m/z: 459 ([M+H]
+
, 100%). HRMS-ESI (m/z): calcd for 
C25H23N4O3S [M+H]
+
 459.1491 found: 459.1490. 
4,6-dimethoxy-2-(4-(1-(4-methylbenzyl)-1H-1,2,3-triazol-4-yl)phenyl)isoindolin-1-one (3b) 
White solid, yield (68%), mp 223-224 °C. IR (KBr) cm
-1
: 3162, 1697 (C=O), 1629, 1613, 1503, 1451, 1196, 1141, 1047, 
1037, 817, 761. 
1
H NMR (300 MHz, CDCl3) δ: 2.38 (s, 3H, CH3), 3.89 (s, 3H, CH3), 3,90 (s, 3H, CH3), 4.74 (s, 2H, CH2), 
5.54 (s, 2H, CH2), 6,63-6,64 (d, J= 3 Hz, 1H), 6.99-7.00 (d, J= 3 Hz, 1H), 7.20-7.26 (m, 4H), 7.64 (s, 1H, CHtriazole), 7.83-
7.86 (m, 2H), 7.93-7.96 (m, 2H). 
13
C NMR (75MHz, CDCl3) δ: 21.2 (CH3), 48.3 (CH2), 54.1 (CH2), 55.6 (CH3), 55.9 (CH3), 
97.9 (CH), 103.0 (CH), 119.1 (CHtriazole), 119.2 (2 CH), 121.3 (C), 126.4 (2 CH), 126.5 (C), 128.2 (2 CH), 129.8 (2 CH), 
131.6 (C), 135.2 (C), 138.8 (C), 139.5 (C), 147.7 (Cq triazole), 155.1 (C), 162.0 (C), 167.6 (C); MS-(+)ESI m/z: 441 ([M+H]
+
, 
100%). HRMS-ESI m/z: calcd for C26H25N4O3 [M+H]
+ 
441.1927 found: 441.1924. 
2-(4-(1-(4-fluorobenzyl)-1H-1,2,3-triazol-4-yl)phenyl)-4,6-dimethoxyisoindolin-1-one (3c) 
White solid, yield (76%), mp 229-230 °C. IR (KBr) cm
-1
: 3188, 1685 (C=O), 1623, 1606, 1504, 1360, 1221, 1143, 1122, 
1045, 842, 767. 
1
H NMR (300 MHz, DMSO-d6) δ: 3.86 (s, 3H, CH3), 3,90 (s, 3H, CH3), 4.88 (s, 2H, CH2), 5.64 (s, 2H, 
CH2), 6,83-6,84 (d, J= 3 Hz, 1H), 6.87-6.88 (d, J= 3 Hz, 1H), 7.21-7.27 (m, 2H), 7.42-7.47 (m, 2H), 7.87-7.90 (m, 2H), 
7.99-7.02 (m, 2H), 8.61 (s, 1H, CHtriazole). 
13
C NMR (75 MHz, DMSO-d6) δ: 48.4 (CH2), 52.7 (CH2), 56.2 (CH3), 56.2 (CH3), 
98.4 (CH), 103.6 (CH), 115.9 (CH), 116.6 (CH), 119.8 (2 CH), 121.6 (CHtriazole), 121.8 (C), 126.2 (2 CH), 126.8 (C), 130.7 
(CH), 130.8 (CH), 132.72 (C), 132.71 (C), 134.9 (C), 139.6 (C), 146.8 (Cq triazole), 155.5 (C), 162.0 (C), 167.0 (C); MS-
(+)ESI m/z: 445 ([M+H]
+
, 100%). HRMS-ESI m/z: calcd for C25H22FN4O3 [M+H]
+ 
445.1676 found: 445.1672. 
2-(4-(1-(4-chlorobenzyl)-1H-1,2,3-triazol-4-yl)phenyl)-4,6-dimethoxyisoindolin-1-one (3d) 
White solid, yield (75%), mp 209-210 °C. IR (KBr) cm
-1
: 3105, 1694 (C=O), 1626, 1608, 1500, 1363, 1272, 1143, 1123, 
1045, 839, 764. 
1
H NMR (300 MHz, CDCl3) δ:  3.90 (s, 3H, CH3), 3,91 (s, 3H, CH3), 4.75 (s, 2H, CH2), 5.56 (s, 2H, CH2), 
6,64-6,65 (d, J= 3 Hz, 1H), 6.99-7.00 (d, J= 3 Hz, 1H), 7.26-7.30 (m, 2H), 7.36-7.41 (m, 2H), 7.68 (s, 1H, CHtriazole), 7.84-
7.87 (m, 2H), 7.94-7.98 (m, 2H). 
13
C NMR (75 MHz, CDCl3) δ: 48.3 (CH2), 53.5 (CH2), 55.6 (CH3), 55.9 (CH3), 97.9 (CH), 
103.1 (CH), 119.2 (CHtriazole), 119.2 (2 CH), 121.3 (C), 126.3 (C), 126.4 (2 CH), 129.4 (4 CH), 129.8 (C), 133.2 (C), 135.2 
(C), 139.7 (C), 147.9 (Cq triazole), 155.1 (C), 162.0 (C), 167.6 (C). MS-(+)ESI m/z: 461 ([M+H]
+
, 100%), 463 ([M+H]
+
, 35%). 
HRMS-ESI m/z: calcd for C25H22ClN4O3 [M+H]
+ 
461.1380 found: 461.1382. 
4,6-dimethoxy-2-(3-(1-(phenylthiomethyl)-1H-1,2,3-triazol-4-yl)phenyl)isoindolin-1-one (3e) 
White solid, yield (80%), mp 179-181 °C. IR (KBr) cm
-1
: 3145, 2965, 2945, 2843, 1713 (C=O), 1624, 1611, 1578, 1506, 
1491, 1436, 1371, 1359, 1345, 1301, 1210, 1148, 1111, 1073, 1046, 1006, 932, 844, 815, 789, 753, 690, 634, 490. 
1
H 
NMR (300 MHz, DMSO-d6) δ: 3.86 (s, 3H, CH3), 3.91 (s, 3H, CH3), 4.91 (s, 2H, CH2), 6.01 (s, 2H, CH2), 6.83-6.84 (d, J= 3 
Hz, 1H), 6.88-6.89 (d, J= 3 Hz, 1H), 7.33-7.37 (m, 3H), 7.44-7.48 (m, 3H), 7.62-7.65 (m, 1H), 7.97-8.01 (m, 1H), 8.26-8.28 
(t, J = 3 Hz, 1H), 8.67 (s, 1H, CHtriazole). 
13
C NMR (300 MHz, DMSO-d6) δ: 48.5 (CH2), 52.5 (CH2), 56.2 (CH3), 56.2 (CH3), 
98.4 (CH), 103.6 (CH), 116.3 (CH), 119.3 (CH), 121.3 (CHtriazole), 121.8 (CH), 121.9 (C), 128.3 (CH), 129.8 (2 CH), 130.0 
(CH), 131.1 (2 CH), 131.6 (C), 132.8 (C), 134.9 (C), 140.6 (C), 147.0 (Cq triazole), 155.5 (C), 162.0 (C), 167.1 (C). MS-(+)ESI 
m/z: 459 ([M+H]
+
, 100%). HRMS- ESI m/z: calcd for C25H23N4O3S [M+H]
+ 
459.1491 found: 459.1483. 
4,6-dimethoxy-2-(3-(1-(4-methylbenzyl)-1H-1,2,3-triazol-4-yl)phenyl)isoindolin-1-one (3f) 
White solid, yield (60%), mp 176-177 °C. IR (KBr) cm
-1
: 3142, 1695 (C=O), 1627, 1608, 1508, 1448, 1386, 1362, 1203, 
1147, 1119, 1053, 887, 756. 
1
H NMR (300 MHz, CDCl3) δ: 2.38 (s, 3H, CH3), 3.89 (s, 3H, CH3), 3,91 (s, 3H, CH3), 4.79 (s, 
2H, CH2), 5.55 (s, 2H, CH2), 6,64-6,65 (d, J= 3 Hz, 1H), 6.98-6.99 (d, J= 3 Hz, 1H), 7.20-7.26 (m, 4H), 7.43-7.49 (t, J= 9 
Hz, 1H), 7.63-7.64 (m, 1H), 7.73 (s, 1H, CHtriazole), 7.94-7.96 (m, 1H), 8.25-8.27 (t, J= 3 Hz, 1H). 
13
C NMR (75 MHz, 
CDCl3) δ: 21.2 (CH3), 48.48 (CH2), 54.1 (CH2), 55.6 (CH3), 55.9 (CH3), 97.9 (CH), 103.1 (CH), 116,1 (CH),  118.9 (CH), 
119.7 (CH), 121.5 (C), 121.5 (CHtriazole), 128.2 (2 CH), 129.6 (CH), 129.9 (2 CH), 131.5 (C), 131.5 (C), 135,2 (C), 138.8 
(C), 140.2 (C), 147.9 (Cq triazole), 155.2 (C), 162.0 (C), 167.7 (C). MS-(+)ESI m/z: 441 ([M+H]
+
, 100%). HRMS-ESI m/z: 
calcd for C26H25N4O3 [M+H]
+ 
441.1927 found: 441.1921. 
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2-(3-(1-(4-fluorobenzyl)-1H-1,2,3-triazol-4-yl)phenyl)-4,6-dimethoxyisoindolin-1-one (3g) 
White solid, yield (65%), mp 189-190 °C. IR (KBr) cm
-1
: 3180, 1702 (C=O), 1629, 1611, 1508, 1365, 1224, 1143, 1114, 
1046, 832, 774. 
1
H NMR (300 MHz, DMSO-d6) δ: 3.86 (s, 3H, CH3), 3,90 (s, 3H, CH3), 4.90 (s, 2H, CH2), 5.75 (s, 2H, 
CH2), 6,83-6.84 (d, J= 3 Hz, 1H), 6.87 -6,88 (d, J= 3 Hz, 1H), 7.20-7.28 (m, 2H), 7.42-7.51 (m, 3H), 7.65-7.67 (m, 1H), 
7.96-8.00 (m, 1H), 8.26-8.28 (m, 1H), 8.70 (s, 1H, CHtriazole). 
13
C NMR (75 MHz, DMSO-d6) δ: 48.5 (CH2), 52.7 (CH), 56.2 
(CH3), 56.2 (CH3), 98.4 (CH), 103.5 (CH), 116,3 (CH),  119.2 (CH), 121.3 (CHtriazole), 121.9 (C), 122.3 (CH), 129.9 (CH), 
130.7 (2 CH), 130.8 (2 CH), 131.8 (C), 132.7 (C), 132,7 (C), 134.9 (C), 140.5 (C), 147.0 (Cq triazole), 155.5 (C), 162.0 (C), 
167.1 (C). MS-(+)ESI m/z: 445 ([M+H]
+
, 100%). HRMS-ESI m/z: calcd for C25H22FN4O3 [M+H]
+ 
445.1676 found: 445.1668. 
2-(3-(1-(4-chlorobenzyl)-1H-1,2,3-triazol-4-yl)phenyl)-4,6-dimethoxyisoindolin-1-one (3h) 
White solid, yield (71%), mp 176-177 °C. IR (KBr) cm
-1
: 3145, 1688 (C=O), 1626, 1609, 1492, 1449, 1362, 1202, 1146, 
1118, 1053, 762. 
1
H NMR (300 MHz, DMSO-d6) δ: 3.86 (s, 3H, CH3), 3,90 (s, 3H, CH3), 4.90 (s, 2H, CH2), 5.75 (s, 2H, 
CH2), 6,83-6.84 (d, J= 3 Hz, 1H), 6.87-6,88 (d, J= 3 Hz, 1H), 7.38-7.51 (m, 5H), 7.65-7.68 (m, 1H), 7.97-8.01 (m, 1H), 
8.26-8.28 (m, 1H), 8.71 (s, 1H, CHtriazole). 
13
C NMR (75 MHz, DMSO-d6) δ: 48.5 (CH2), 52.7 (CH), 56.2 (CH3), 56.2 (CH3), 
98.4 (CH), 103.5 (CH), 116,3 (CH),  119.2 (CH), 121.3 (CHtriazole), 121.9 (C), 122.4 (CH), 129.3 (2 CH), 130.0 (CH), 130.4 
(2 CH), 131.8 (C), 133,4 (C), 134.9 (C), 135.4 (C), 140.5 (C), 147.0 (Cq triazole), 155.5 (C), 162.0 (C), 167.1 (C); MS-(+)ESI 
m/z: 461 ([M+H]
+
, 100%), 463 ([M+H]
+
, 35%). HRMS-ESI m/z: calcd for C25H22ClN4O3 [M+H]
+
 461.1380 found: 461.1371. 
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